Tci GeneROCO:6879 65 FCF Yield % is 15.42 as of Jul. 03, 2026, which is 316% above its 10-year median of 3.71. GuruFocus rates ROCO:6879 with a GF Score™ of 65/100 and a GF Value™ of NT$49.25 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,413 Biotechnology companies, Tci Gene ranks better than 98.44% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Tci Gene's Trailing 12-Month Free Cash Flow is NT$150.9 Mil, and Market Cap is NT$979.0 Mil. Therefore, Tci Gene's FCF Yield % for today is 15.42%.
The historical rank and industry rank for Tci Gene's FCF Yield % or its related term are showing as below:
ROCO:6879'
s FCF Yield % Range Over the Past 10 Years
Min: 0.63 Med: 3.71 Max: 16.68
Current: 15.42
During the past 7 years, the highest FCF Yield % of Tci Gene was 16.68%. The lowest was 0.63%. And the median was 3.71%.
ROCO:6879's FCF Yield % is ranked better than 98.44% of 1413
companies
in the Biotechnology industry
Industry Median: -9.25
vs ROCO:6879: 15.42
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Tci Gene FCF Yield % Related Terms
Tci Gene FCF Yield % Historical Data
* Premium members only.
The historical data trend for Tci Gene's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6879 vs VRTX, REGN, ALNY: FCF Yield % Comparison
For the Biotechnology subindustry, Tci Gene's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tci Gene FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tci Gene's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Tci Gene's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tci Gene (ROCO:6879) has a FCF Yield % of 15.42 as of Jul. 03, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Tci Gene and its competitors. This is 316% above median its historical median of 3.71. Over the past decade, Tci Gene's FCF Yield % has ranged from 0.63 to 16.68. According to the industry distribution chart, Tci Gene ranks #22 out of 1413 companies in the Biotechnology industry, placing it in the top 1.6%.
Is Tci Gene's FCF Yield % too high?
Tci Gene's current FCF Yield % of 15.42 is 316% above median its 10-year median of 3.71. Over the past 10 years, this metric has ranged from a low of 0.63 to a high of 16.68. Based on the distribution chart, Tci Gene ranks #22 out of 1413 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Tci Gene has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tci Gene's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Tci Gene ranks #22 out of 1413 companies for FCF Yield %. This places Tci Gene in the top 2% of its industry — outperforming the majority of peers. Historically, Tci Gene's own FCF Yield % has ranged from 0.63 to 16.68 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Tci Gene and its competitors. Tci Gene's current FCF Yield % is 15.42, which is 316% above median its own 10-year median of 3.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tci Gene stock overvalued right now?
Based on GuruFocus' analysis, Tci Gene (ROCO:6879) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$49.25, compared to a current price of NT$37.00 — trading 24.9% below its estimated fair value. The current FCF Yield % is 15.42, which is 316% above median its 10-year median of 3.71. Tci Gene's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Tci Gene (ROCO:6879), the current FCF Yield % is 15.42 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tci Gene (ROCO:6879) Overvalued in 2026?
Based on GuruFocus' analysis, Tci Gene stock appears to be undervalued.
The current stock price of NT$37.00 is trading 24.9% below its estimated GF Value™ of NT$49.25.
GuruFocus considers Tci Gene to be Modestly Undervalued.
Key valuation signals for ROCO:6879:
FCF Yield %: 15.42 (316% above median its 10-year median of 3.71)
GF Value™: NT$49.25 vs. price of NT$37.00 (24.9% below fair value)
No single metric tells the full story. See the ROCO:6879 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.
65GF Score
Get the complete analysis for ROCO:6879
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6879 has been successfully added to your 
